Published in Medical Letter on the CDC and FDA, February 11th, 2007
The system is the first of its kind in North America to treat patients with congenital and acquired structural heart disease requiring pulmonary valve replacement.
The Melody valve and Ensemble delivery system are designed for patients with congenital heart defects involving the connection between their right ventricle and pulmonary artery. Oftentimes, this type of defect requires open heart surgery early in life to implant a prosthetic valved conduit to establish...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.